RefloDx Overview

  • Founded
  • 2015
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 2

RefloDx General Information


Developer of a Gastroesophageal Reflux (GER) diagnostic tool designed for early detection and characterization of reflux events to guide treatment. The company's diagnostic tool uses ultrasound to non-invasively detect and characterize GER in a home setting, enabling patients to live a healthy life and ameliorate their sufferings from gastrointestinal problems.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Diagnostic Equipment
Primary Office
  • 633 North Falcon Hill Drive
  • Clearfield, UT 84015-3254
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

RefloDx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 01-May-2020 Completed Startup
2. Accelerator/Incubator 20-Dec-2017 Completed Startup
1. Grant 01-Jan-2017 $225K Completed Startup
To view RefloDx’s complete valuation and funding history, request access »

RefloDx Executive Team (2)

Name Title Board Seat Contact Info
Andrew Wilcox Co-Founder
Samuel Thomas MD Co-Founder
To view RefloDx’s complete executive team members history, request access »

RefloDx Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Utah Science Technology and Research Initiative Government 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0
To view RefloDx’s complete investors history, request access »